Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery Cytokeratin 18

Path Created with Sketch.
Go to Cytokeratin 18 Normal Tissue Gallery Go back to Product Page
Breast cancer - Strong diffuse CK18 positivity in a breast cancer NST.
Breast cancer – Strong diffuse CK18 positivity in a breast cancer NST.
Cervical cancer - Adenocarcinoma of the cervix uteri with intense CK18 positivity.
Cervical cancer – Adenocarcinoma of the cervix uteri with intense CK18 positivity.
Colorectal cancer - Adenocarcinoma of the colon with strong CK18 immunostaining.
Colorectal cancer – Adenocarcinoma of the colon with strong CK18 immunostaining.
Head and neck cancer - CK 18 negative squamous cell carcinoma of the larynx. Normal glandular cells serve as a positive staining control.
Head and neck cancer – CK 18 negative squamous cell carcinoma of the larynx. Normal glandular cells serve as a positive staining control.
Kidney cancer - Strong CK18 immunostaining in chromophobe renal cell carcinoma.
Kidney cancer – Strong CK18 immunostaining in chromophobe renal cell carcinoma.
Ovarian cancer - Strong CK18 immunostaining in a high grade serous carcinoma of the ovary.
Ovarian cancer – Strong CK18 immunostaining in a high grade serous carcinoma of the ovary.
Sarcoma - Weak to moderate CK18 neo-expression in a sarcoma NOS.
Sarcoma – Weak to moderate CK18 neo-expression in a sarcoma NOS.
Stomach cancer - strong diffuse CK18 expression in an intestinal type stomach adenocarcinoma.
Stomach cancer – strong diffuse CK18 expression in an intestinal type stomach adenocarcinoma.
Testicular cancer - Yolk sac carcinoma with strong CK18 immunostaining.
Testicular cancer – Yolk sac carcinoma with strong CK18 immunostaining.
Urinary bladder cancer - Strong diffuse CK18 expression in a muscle-invasive urothelial carcinoma.
Urinary bladder cancer – Strong diffuse CK18 expression in a muscle-invasive urothelial carcinoma.
Urinary bladder cancer - Strong diffuse CK18 immunostaining in a (micropapillary) urothelial carcinoma.
Urinary bladder cancer – Strong diffuse CK18 immunostaining in a (micropapillary) urothelial carcinoma.
Vaginal cancer - Absence of CK18 immunostaining in a squamous cell carcinoma of the vagina.
Vaginal cancer – Absence of CK18 immunostaining in a squamous cell carcinoma of the vagina.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors